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Abstract 
Background: The aim of this study was to assess the benefit of direct ICU admission from the emergency depart‑
ment (ED) compared to admission from wards, in patients with hematological malignancies requiring critical care.
Methods: Post hoc analysis derived from a prospective, multicenter cohort study of 1011 critically ill adult patients 
with hematologic malignancies admitted to 17 ICU in Belgium and France from January 2010 to May 2011. The vari‑
able of interest was a direct ICU admission from the ED and the outcome was in‑hospital mortality. The association 
between the variable of interest and the outcome was assessed by multivariable logistic regression after multiple 
imputation of missing data. Several sensitivity analyses were performed: complete case analysis, propensity score 
matching and multivariable Cox proportional‑hazards analysis of 90‑day survival.
Results: Direct ICU admission from the ED occurred in 266 (26.4%) cases, 84 of whom (31.6%) died in the hospital 
versus 311/742 (41.9%) in those who did not. After adjustment, direct ICU admission from the ED was associated with 
a decreased in‑hospital mortality (adjusted OR: 0.63; 95% CI 0.45–0.88). This was confirmed in the complete cases 
analysis (adjusted OR: 0.64; 95% CI 0.45–0.92) as well as in terms of hazard of death within the 90 days after admis‑
sion (adjusted HR: 0.77; 95% CI 0.60–0.99). By contrast, in the propensity score‑matched sample of 402 patients, direct 
admission was not associated with in‑hospital mortality (adjusted OR: 0.92; 95% CI 0.84–1.01).
Conclusions: In this study, patients with hematological malignancies admitted to the ICU were more likely to be 
alive at hospital discharge if they were directly admitted from the ED rather than from the wards. Assessment of early 
predictors of poor outcome in cancer patients admitted to the ED is crucial so as to allow early referral to the ICU and 
avoid delays in treatment initiation and mis‑orientation.
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Background
One of the goals of emergency physicians is to detect, 
based on clinical characteristics and physiological 
derangements, patients without established organ dys-
function, but who are at high risk of early life-threatening 
complications. Such patients should be early admitted to 
the intensive care unit (ICU) or high dependency units 
as to benefit from close monitoring. Indeed, when these 
patients are admitted to classic wards, the level of moni-
toring may be inappropriate. Moreover, the workload 
that these high-risk patients impose to clinicians also 
hampers optimal management of remaining patients. 
The occurrence of complications in wards could lead to 
delays in patient optimal care and transfer to the ICU 
and, therefore, increase morbi-mortality [1]. This is even 
more likely for immunocompromised patients in whom 
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the risk of deterioration is higher and less easily predict-
able [2].
Thus, we hypothesized that immunocompromised 
patients admitted to the ICU directly from the emer-
gency department (ED), were admitted sooner and, may 
have better outcomes compared to similar patients, 
admitted to ICU from the wards.
The aim of this study was to assess the benefit of direct 
ICU admission from the ED compared to admission 
from wards, in patients with hematological malignancies 
requiring critical care.
Methods
This is a post hoc analysis derived from a prospec-
tive, multicenter cohort study of 1011 critically ill adult 
patients with hematologic malignancies admitted to 17 
ICUs in Belgium and France from January 1, 2010 to May 
1, 2011 [3]. Briefly, the study was carried out in university 
or university-affiliated centers in France and Belgium that 
belonged to a research network instituted in 2005. In all 
17 centers, a senior intensivist and a senior hematologist 
are available around the clock and make ICU-admission 
decisions together.  During the study period, consecu-
tive patients having hematologic malignancies who were 
admitted to the participating ICUs for any reason were 
included. Exclusion criteria were complete cure of the 
malignancy for more than 5  years, ICU admission only 
to maximize safety of a procedure, and age younger than 
18 years. For this post hoc analysis, patients with missing 
data on the outcome were also excluded. The study was 
approved by the appropriate ethics committees in France 
and Belgium. All patients or relatives were informed and 
consented to participate in the study.
Data collection and outcome measure
Data abstracted from the study database were: age, sex, 
underlying malignancy, disease status (newly diagnosed 
if malignancy was diagnosed in the last month, complete 
or partial remission, other), autologous or allogeneic 
bone marrow or hematopoietic stem-cell transplantation 
(BMT/HSCT), treatment with long-course corticoster-
oids, Charlson comorbidity index, performance status, 
existence of organ failure based on the Sequential-related 
Organ Failure Assessment (SOFA) criteria, SOFA score, 
main reason for ICU admission, circumstances of ICU 
admission, time between hospital and ICU first request, 
and between first request and ICU admission, number of 
requests before ICU admission, specialty and experience 
of the physician that requested ICU admission, direct 
admission from the ED, length of ICU and hospital stay, 
vital status at ICU, at hospital discharge, and at day 90.
The variable of interest was direct admission from the 
ED, and the main outcome was in-hospital mortality.
Statistical analysis
Results are reported as medians with interquartile ranges 
(IQR) for continuous variables and numbers with per-
centages for binary and categorical variables.
Patient characteristics were compared using the Chi-
square test for categorical variables and the Wilcoxon 
rank sum test or the Student t test, as appropriate, for 
continuous variables (with normality tested with Shap-
iro–Wilk test). We investigated the association between 
the variable of interest and the outcome by multivari-
able logistic regression to search for potential confound-
ers. Characteristics associated with the outcome on the 
basis of P-values less than 0.1 by univariable analyses 
were included in a multivariable logistic model; clinically 
relevant prognostic characteristics such as SOFA score, 
Charlson risk index or performance status, were forced 
in the model regardless of their P value. Then, a backward 
selection procedure was applied, except for clinically rel-
evant prognostic variables that were not removed from 
the model.
Missing data were managed with multiple imputation 
by chained equations [4]. The distribution of the data 
according to the presence or absence of missing data was 
checked (plots if continuous or tables if categorical varia-
bles) to ensure that missing data were missing completely 
at random. As recommended [5], variables included in 
the imputation model were those of the logistic regres-
sion prediction model (including the outcome), in addi-
tion to auxiliary covariates correlated with the missing 
variables (i.e., sex, underlying disease, days since diagno-
sis, days between first call to intensivist and ICU admis-
sion, experience of the physician requesting ICU, number 
of calls before ICU admission, organ failures). Five data-
sets were imputed with 50 iterations each. Multivariable 
logistic regression model was applied to the 5 imputed 
datasets and final estimates were obtained by averaging 
the 5 estimates according to Rubin’s rules.
Several sensitivity analyses were performed. First, a 
complete cases analysis was performed. Second, to han-
dle potential residual confounding by indication, a pro-
pensity score matching was done, where propensity 
score of being directly ICU admitted was estimated from 
a multivariable logistic model, with resulting balances 
in confounders checked by standardized mean differ-
ences and c-index [6], then matching performed without 
replacement within a caliper of 0.2 standard deviation 
of the logit of propensity score [7]. Third, we plotted 
survival Kaplan–Meier curve (from ICU admission to 
90  days) according to direct admission status from the 
ED. Hazards ratio (HR) from Cox proportional-hazards 
models was used to quantify the association between the 
direct admission status and the outcome, adjusting for 
baseline predictors of survival. Underlying assumptions 
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of the Cox model were checked: Proportional hazards 
(PH) assumption was tested using a formal test based 
on the Schoenfeld residuals, with time-dependent effect 
considered for covariates that violated the PH assump-
tion [8]. Log-linearity between non-binary covariates and 
hazard was assessed through splines; in case of nonlinear 
effect, covariates were dichotomized according to thresh-
olds derived from the splines.
All P-values were two-sided, with values of 0.05 or less 
considered as statistically significant.
Data were analyzed with R 3.5.0 software (the R Foun-
dation for Statistical Computing, Vienna, Austria).
Results
General characteristics
During the study period, 1011 patients were enrolled. 
Due to missing data on the outcome, 3 patients were 
excluded leading to a number of 1008 included patients 
in the analysis. Table 1 shows the patients’ characteristics 
at ICU admission.
Patients were mostly men (60.7%) and half were aged 
of less than 60 years. The most frequent malignancy was 
non-Hodgkin’s lymphoma (31.6%), followed by acute 
myeloid leukemia (27.2%) and myeloma (12.5%). Chronic 
malignancy as chronic lymphocytic or myeloid leuke-
mia or myelodysplastic syndrome was present in 13.9% 
of the patients. Disease status was complete or partial 
remission or newly diagnosed for 64.3% of the patients. 
One hundred and ninety-eight patients (19.8%) had poor 
performance status. The most frequent main reasons for 
ICU admission were acute respiratory failure (39.2%) and 
sepsis (26.8%). Patients had respiratory failure in 62.7% 
cases, cardiovascular failure in 42.3% cases, renal failure 
in 30.3% cases, and neurological failure in 22.4% cases.
Direct ICU admission from the ED and hospital mortality
Table  2 shows the modalities of ICU admission. ICU 
admission was requested by the hematologist in 59.3% 
of the cases and by an emergency physician in 22% of 
the cases. Physicians requested ICU transfer in the 4 
[0–17]  days after patient hospital admission. Patients 
were admitted to ICU most of the time by the day of 
the request (97.6%) and after one call to the intensivist 
(87.7%). Direct ICU admission from the ED occurred 
for 266 (26.4%) patients (Fig. 1). Patients stayed in ICU 
5 [2–11] days in median. ICU and in-hospital mortality 
were 27.7% and 39.2%, respectively. 
By univariable analyses (Additional file  1), variables 
associated with in-hospital mortality were an age > 60 
(44% vs. 34.6%; P = 0.003), non-complete or non-partial 
remission or non-newly diagnosed disease status (45.6% 
vs. 36.2%; P = 0.005), allogeneic BMT/HSCT recipient 
(52.1% vs. 36.9%; P < 0.0001), a high Charlson comor-
bidity index (median: 4; IQR: 3 to 6 vs median: 4; IQR: 2 
to 5; P = 0.0001), a poor performance status (57.1% vs. 
34.7%; P < 0.0001), a high SOFA score (median: 7; IQR 5 
to 11 vs median: 5; IQR 3 to 7; P < 0.0001), time between 
hospitalization and first call to the intensivist (median: 
7; IQR 1 to 21 vs median: 2; IQR 0 to 14; P < 0.0001), an 
ICU admission requested by a non-emergency physi-
cian (41.3% vs. 31.5%; P = 0.01). Conversely, direct ICU 
admission from the ED was associated with decreased 
in-hospital mortality (31.6% vs. 41.9%; P = 0.004). 
Table  3 reports the estimated effect of direct ICU 
admission on the in-hospital mortality adjusted on 
prognostic variables, based on the multivariable logistic 
model after multiple imputation. Direct ICU admission 
from the ED was associated with decreased in-hospital 
mortality (OR: 0.63; 95% CI 0.45 to 0.88).
Sensitivity analyses
Figure 2 summarizes the estimated effects of direct ICU 
admission from the ED on in-hospital mortality depend-
ing on the sensitivity analysis.
First, the complete cases analysis confirmed the 
improved survival of direct ICU admission (OR: 0.64; 
95% CI 0.45–0.92).
Secondly, based on propensity score, 201 patients 
admitted to the ICU directly from the ED were matched 
with patients admitted from wards. Additional file  2 
reports differences in patient characteristics according 
to location prior to ICU admission before matching and 
Additional file 3 shows the absolute mean differences in 
patient characteristics before and after matching on pro-
pensity score. In the matched sample of 402 patients, 
direct admission was not associated with in-hospital 
mortality (OR: 0.92; 95% CI 0.84–1.01).
Last, survival was significantly improved in patients 
who were admitted directly to the ICU from the ED 
(Fig. 3), with an estimated unadjusted HR at 0.75 (95% CI 
0.59–0.94, P = 0.014). After adjustment on survival pre-
dictors (namely, disease status, BMT/HSCT, Charlson 
comorbidity index, performance status and SOFA score 
at ICU admission), the adjusted HR was 0.77 (95% CI 
0.60 to 0.99, P = 0.04).
Discussion
In this post hoc analysis derived from a prospective, mul-
ticenter cohort study of 1011 critically ill adults patients 
with hematologic malignancies admitted to ICU, direct 
admission from the ED was associated with decreased 
in-hospital mortality in comparison with admission from 
the wards. This effect on mortality was confirmed in 
most of the sensitivity analyses except after matching on 
propensity score.
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Benefit from appropriate and prompt ICU manage-
ment is an established fact in myocardial infarction 
[9], ischemic stroke [10] or major trauma [11]. Along 
this line, early ICU admission of patients with some 
physiological derangement, before organ dysfunc-
tion actually develops, may be beneficial. Chalfin et al. 
showed that among 50,322 patients admitted to the 
ICU from the ED, those admitted with a ≥ 6 h delay had 
higher increased hospital length of stay (7 vs. 6  days, 
P < 0.001) and higher ICU and hospital mortality rates 
(10.7% vs. 8.4%, P < 0.01 and 17.4% vs. 12.9%, respec-
tively, P < 0.001) [12]. This is also in agreement with the 
Renaud et  al. study where patients with community-
acquired pneumonia had different survival according 
to whether they were admitted to the ICU early, late 
or not admitted to the ICU (adjusted OR 2.63; 95% CI 
1.42–4.90 for patients admitted early to the ICU) [13].
Table 1 Patients’ characteristics at ICU admission
BMT bone marrow transplantation, HSCT hematopoietic stem-cell transplantation, ICU intensive care unit, IQR interquartile range, PS performance status, SOFA 
Sequential Related Organ Failure Assessment
Characteristics Overall cohort 
(N = 1008)
Status at hospital discharge Missing data
Alive (n = 613) Death (n = 395)
Age, median [IQR], years 60 [49–69] 59 [47–68] 62 [52–71] 0
Female gender, n (%) 396 (39.3) 252 (41.1) 144 (36.4) 0
Underlying malignancy, n (%) 0
 Non‑Hodgkin’s lymphoma 319 (31.6) 190 (31.0) 129 (32.7)
 Acute myeloid leukemia 274 (27.2) 162 (26.4) 112 (28.4)
 Myeloma 126 (12.5) 86 (14.0) 40 (10.1)
 Chronic lymphocytic leukemia 75 (7.4) 45 (7.3) 30 (7.6)
 Acute lymphocytic leukemia 73 (7.2) 44 (7.2) 29 (7.3)
 Myelodysplastic syndrome 46 (4.6) 26 (4.2) 20 (5.1)
 Hodgkin’s disease 25 (2.5) 18 (2.9) 7 (1.8)
 Chronic myeloid leukemia 19 (1.9) 14 (2.3) 5 (1.3)
 Other 51 (5.1) 28 (4.5) 23 (5.8)
Disease status, n (%) 54
 Complete or partial remission 232 (24.3) 154 (26.6) 78 (20.7)
 Newly diagnosed 382 (40.0) 238 (41.2) 144 (38.2)
 Other 340 (35.6) 185 (32.1) 155 (41.1)
Days since diagnosis, median [IQR] 169 [7–965] 163 [7–1015] 174 [10–942] 97
Allogeneic BMT/HSCT recipient, n (%) 146 (14.5) 70 (11.4) 76 (19.3) 3
Long course corticosteroids, n (%) 381 (38) 218 (35.7) 163 (41.6) 5
Charlson comorbidity index, median [IQR] 4 [3–6] 4 [2–5] 4 [3–6] 1
Poor PS (> 2), n (%) 198 (19.8) 85 (13.9) 113 (28.8) 6
Reason for ICU admission, n (%) 55
 Acute respiratory failure 374 (39.2) 205 (35.6) 169 (44.8)
 Sepsis or septic shock 255 (26.8) 166 (28.8) 89 (23.6)
 Metabolic disorder or acute kidney injury 111 (11.6) 73 (12.7) 38 (10.1)
 Coma 69 (7.2) 41 (7.1) 28 (7.4)
 Other 144 (15.5) 91 (15.8) 53 (14.1)
Organ failure, n (%) 2
 Respiratory 631 (62.7) 344 (56.1) 287 (73.0)
 Hemodynamic 426 (42.3) 236 (38.5) 190 (48.3)
 Renal 305 (30.3) 171 (27.9) 134 (34.0)
 Neurological 226 (22.4) 114 (18.6) 112 (28.4)
 Coagulation 194 (19.3) 99 (16.1) 95 (24.2)
 Hepatic 83 (8.3) 39 (6.4) 44 (11.2)
 Multi‑organ 549 (54.5) 289 (47.1) 260 (66.0)
SOFA score, median [IQR] 6 [3–9] 5 [3–7] 7 [5–11] 1
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The use of ICU resources needs to be carefully dis-
cussed, however. Bed availability remains a major 
determinant of outcomes in settings where ICU 
resources are scarce [14]. Similarly, Cardoso et al. [15] 
found that delayed admission of patients requiring ICU 
management but for whom no bed was available had 
worse outcome than patients admitted immediately. 
They found that each waiting hour was independently 
associated with a 1% increase in risk of hospital death 
(hazard ratio = 1.010; 95% CI 1.002 to 1.018).
Patients with subtle physiological derangements that 
could foreshadow organ failure must be close moni-
tored so as to prevent secondary deterioration. Hence, 
it may be hazardous to have these patients transferred 
to the wards. In a cohort of 841 septic patients trans-
ferred from the ED to the wards, Whittaker et al. [16] 
reported that 12.5% of patients were transferred to the 
ICU within 48 h and/or died within 28 days of admis-
sion. In this study, cancer was an independent risk 
factor of adverse outcome. Other studies have shown 
that septic patients admitted to ICU from wards had 
higher mortality rates [17, 18]. Last, in a study of cancer 
patients for whom an ICU admission was requested, 
20% of the patients transferred to the wards because 
they were “too well” died [19]. This study suggests 
that ICU admission might have been inappropriately 
delayed and that delayed admission is associated with a 
high mortality rate.
Benefits from early ICU admission have also been 
reported in high-risk patients with malignancies and 
acute respiratory failure. In a prospective study on 219 
patients with cancer admitted to the ICU for acute res-
piratory failure in France conducted by Mokart et  al. 
[20], time between respiratory symptoms onset and ICU 
admission of at least 2 days was an independent predictor 
Table 2 Modalities of ICU admission and hospital mortality
ED emergency department, ICU intensive care unit, IQR interquartile range
Characteristics Overall cohort 
(N = 1008)
Status at hospital discharge Missing data
Alive (n = 613) Dead (n = 395)
Days between hospitalization and first call to inten‑
sivist, median [IQR]
4 [0–17] 2 [0–14] 7 [1–21] 44
Days between first call to intensivist and ICU admis‑
sion, median [IQR]
0 [0–0] 0 [0–0] 0 [0–0] 5
ICU admission requested by, n (%) 12
 Emergency physician 219 (22.0) 150 (24.7) 69 (17.7)
 Other 777 (78.0) 456 (75.2) 321 (82.3)
Experience of the physician requesting ICU, n (%) 25
 Senior physician 651 (66.2) 387 (64.3) 264 (69.3)
 Fellow 170 (17.3) 112 (18.6) 58 (15.2)
 Resident/intern 162 (16.5) 103 (17.1) 59 (15.5)
Number of calls before ICU admission, n (%) 151
 1 752 (87.7) 474 (88.9) 278 (85.8)
 ≥ 2 105 (12.3) 59 (11.1) 46 (14.2)
Direct ICU admission from the ED, n (%) 266 (26.4) 182 (29.7) 84 (21.3) 0
ICU length of stay, median [IQR], days 5 [2–11] 5 [2–9] 5 [2–13] 0
Hospital length of stay, median [IQR], days 28 [13–47] 29 [16–47] 25 [9–47] 39
Death at ICU discharge, n (%) 279 (27.7) 0 (0) 279 (70.6) 0
n=742
Delayed admissionDirect admission
n=266
ICU
Home, consult, prehospital care, ED
n=1008
ED, emergency department; ICU, intensive care unit
Wards
Fig. 1 Flowchart of patients depending on their modalities of 
admission to ICU
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of day-28 mortality (OR: 2.65; 95% CI 1.29–5.44). In the 
present study, neither the delay between ICU request 
and ICU admission nor the number of calls before ICU 
admission was associated with in-hospital mortality 
by univariable analyses. These two variables were not 
included in the logistic regression model because of their 
colinearity with our variable of interest. Early detec-
tion of physiological derangement to allow prompt ICU 
admission is crucial and may be compromised in wards 
where surveillance is not optimal. Dedicated emergency 
teams have shown to be beneficial in case of soon inter-
vention. After implementation of a medical emergency 
team in a comprehensive cancer center in Seoul [21], 
Song et  al. [2] showed that in-hospital mortality rates 
increased significantly with increasing quartiles of time 
from physiological derangement to medical emergency 
team intervention in 199 critically ill cancer patients 
admitted to the ICU. Late intervention after 1.5  h after 
physiological derangement was significantly associated 
with in-hospital mortality in the multivariable analysis 
with adjustment for propensity score (OR: 3.91; 95% CI 
1.93 to 7.94). These results remained true for long-term 
mortality in a study including 525 patients with cancer 
where early intervention was significantly associated with 
1-year mortality after adjusting for potential confounders 
(hazard ratio: 0.456; 95% CI 0.348 to 0.597) [22].
Deciding the accurate timing for ICU admission may 
be challenging. ICU referral or admission decisions may 
be even more difficult in cancer patient when prognosis 
is uncertain [23]. Studies to incite early ICU management 
in high-risk patients are warranted. Besides survival ben-
efits, organ dysfunction recovery and ability to receive 
optimal cancer care are critical endpoints of such 
interventions.
Limitations
Our study has several limitations. First, this was a post 
hoc analysis of a cohort study dealing with the com-
parison of non-randomized groups. Obviously, because 
randomizing modalities of ICU admission may be com-
plex, baseline characteristics of patients admitted from 
wards differ from those admitted directly from the ED. 
To handle these differences and limit selection bias, we 
performed a multivariable logistic regression to incor-
porate differences in baseline characteristics of these 
groups; however, it is possible that non-observed con-
founding factors exist such as hospital bed availability. 
Secondly, estimated benefit disappeared in the propen-
sity score-matched sample, but this may be at least par-
tially due to a lack of power given the limited sample size 
(402 vs. 1008) and on differences between matched and 
unmatched patients resulting in a selected population. 
However, variables that differed between both groups 
were already part of the multivariable logistic regres-
sion, except the type of underlying malignancy and the 
use of long-term corticosteroids. Thus, we reran a second 
multivariable analysis including these two variables and 
direct ICU admission remained associated with a better 
outcome. Third, we focus our research on patients with 
hematological malignancies admitted to the ICU and did 
Table 3 Multivariable analysis. Variables independently associated with hospital mortality
BMT bone marrow transplantation, ED emergency department, HSCT hematopoietic stem-cell transplantation, ICU intensive care unit, PS performance status, SOFA 
Sequential-Related Organ Failure Assessment
Variables Model without imputation (N = 898) Model with imputation (N = 1008)
OR 95% CI P OR 95% CI P
Direct admission to the ICU from the ED 0.64 (0.45 to 0.92) 0.02 0.63 (0.45 to 0.88) 0.007
Age > 60 years 1.47 (1.04 to 2.10) 0.03 1.47 (1.05 to 2.04) 0.02
Disease status
 Remission or newly diagnosed 1.00
 Other 1.49 (1.08 to 2.06) 0.01 1.52 (1.12 to 2.07) 0.008
Allogeneic BMT/HSCT recipient 2.46 (1.57 to 3.86) < 0.0001 2.42 (1.58 to 3.71) < 0.0001
Charlson (/point) 1.06 (0.99 to 1.14) 0.10 1.07 (1.00 to 1.15) 0.04
Poor PS (> 2) 1.88 (1.30 to 2.72) < 0.001 1.99 (1.40 to 2.83) 0.0001
SOFA score (/point) 1.24 (1.19 to 1.29) < 0.00001 1.23 (1.19 to 1.28) < 0.00001
Reason for ICU admission
 Sepsis or septic shock 1.00
 Acute respiratory failure 2.16 (1.47 to 3.2) < 0.001 2.11 (1.45 to 3.06) < 0.0001
 Coma 1.68 (0.89 to 3.15) 0.10 1.72 (0.94 to 3.15) 0.08
 Metabolic disorder or acute kidney injury 2.05 (1.17 to 3.56) 0.01 2.12 (1.24 to 3.62) 0.006
 Other 2.17 (1.30 to 3.63) 0.003 2.25 (1.38 to 3.67) 0.001
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not consider patients admitted to the wards who did not 
require or who were not referred to the ICU. Further-
more, patients admitted to the ICU from wards were not 
necessarily managed in the ED before. Fourth, we could 
not assess the time elapsed between the need for and the 
actual ICU admission. It could have been interesting to 
determine if patients admitted in wards had longer delays 
between first symptoms and ICU admission reflecting 
flaws in monitoring. Fifth, we did not consider the out-
comes after hospital discharge. It is possible that a sub-
stantial part of these patients was transferred to palliative 
care unit lowering the benefit of survival at discharge.
Conclusions
In summary, in this post hoc study, patients with hema-
tological malignancies admitted to the ICU were more 
likely to be alive at hospital discharge if they were directly 
admitted from the ED rather than from the wards. We are 
not yet to pretend that patients admitted to the ICU from 
wards who were previously managed in the ED should 
have been directly admitted from there. We, however, 
put forward that these high-risk patients need prompt 
specific management and close monitoring when they 
develop subtle physiological derangement to anticipate 
organ dysfunctions. This close monitoring may be inade-
quate in the wards and should be achieved by specialized 
teams in intensive care or high dependency units. Assess-
ment of alarm signs and early predictors of poor outcome 
Fig. 2 Effects of direct ICU admission from the ED on hospital mortality
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in cancer patients admitted to the ED is crucial so as to 
allow early referral to the ICU and avoid delays in treat-
ment initiation and mis-orientation.
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